Specifically, higher serum FGF21 concentrations have been described in humans with obesity and diabetes, suggesting the potential presence of FGF21 resistance in addition to insulin resistance [51-54]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.